NERV Earnings & Financial Statements
Minerva Neurosciences, Inc.
$3.27
-$0.16(-4.66%)
23
Overall
40
Value
10
Tech
21
Quality
Market Cap
$163.77M
Volume
106.47K
52W Range
$2.08 - $12.46
Target Price
$10.33
NERV earnings and financial statements: Minerva Neurosciences, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
NERV Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating income | -$15.10M | -$21.85M | -$23.12M | -$25.23M | -$45.37M |
| EBITDA | -$293.42M | $1.46M | -$29.97M | -$17.29M | -$45.28M |
| Net income | -$293.42M | $1.44M | -$30.01M | -$32.11M | -$49.91M |
| EPS (diluted) | $-34.67 | $0.19 | $-4.61 | $-6.01 | $-9.36 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $97.97M | $37.14M | $56.90M | $55.09M | $77.12M |
| Total liabilities | $233.76M | $62.84M | $85.36M | $75.11M | $69.15M |
| Shareholders’ equity | -$140.75M | -$25.69M | -$28.46M | -$20.02M | $7.98M |
| Cash and equivalents | $82.30M | $21.36M | $40.91M | $36.09M | $60.76M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$13.50M | -$19.55M | -$14.78M | -$24.65M | -$24.60M |
| Capital expenditure | - | - | - | -$16.3K | - |
| Free cash flow | -$13.50M | -$19.55M | -$14.78M | -$24.66M | -$24.60M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NERV | $3.27 | -4.7% | 106.47K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Minerva Neurosciences, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW